Recent Articles

• 
  Semiconductor

  Chey Tae-won: New Chip Plant May Go Abroad

  Chey Tae-won, Chairman of SK Group (photo), stated on the 10th regarding the location of a new semiconductor plant that “it may not necessarily be the case that we will build it in Korea no matter what,” indicating that both domestic and overseas sites are being considered. His remarks came as some

  2026.06.11
• 
  Global Business

  Cross-Border E-Commerce Surges 77% on Weak Won

  As demand from overseas “reverse direct purchase” consumers seeking Korean products surges on the back of a weak won, domestic retail companies are accelerating their push into the cross-border e-commerce market. The popularity of K-content is also expanding demand for K-beauty and K-food, and with

  2026.06.11
• 
  Anthropic

  Anthropic Publicly Releases Top-Tier Mythos-Level AI ‘Fable 5’

  The AI company Anthropic, which is preparing for an initial public offering (IPO), has released to the public a top-tier artificial intelligence (AI) model at the level of its previously undisclosed flagship model “Mythos.” The company has simultaneously introduced safety mechanisms to block potenti

  2026.06.11
• 
  Semiconductor

  SK hynix Rally Boosts Public Profile, Brand Value

  On the 10th, Interbrand Global CEO Gonzalo Brujó (left) and Moon Ji-hoon, head of Interbrand Korea, at the Korean office of Interbrand in Gangnam-gu, Seoul. Provided by Interbrand “This was a year in which the landscape of brand value changed dramatically due to the spread of artificial intelligence

  2026.06.11
• 
  Samsung

  Samsung Becomes Top Shareholder in US Element, Speeds Medtech Commercialization

  Samsung Electronics has become the largest shareholder of Element Biosciences (Element), a U.S. gene analysis equipment company. The move is part of an expansion of its “medtech (medical technology and devices)” business, which was identified as a future growth engine under the late Chairman Lee Kun

  2026.06.11
• 
  Global Investment

  SKT, NTT, Chunghwa Telecom Launch AI Fund

  On 10 June, SK Telecom Chief Executive Officer (CEO) Jung Jae-heon speaks about the significance of the Korea-Japan economic alliance and the establishment of the “IOWN AI Fund” at a press conference held at NTT’s head office in Tokyo, Japan, with SKT, Japan’s ICT group NTT, and Taiwan’s Chunghwa Te

  2026.06.11
• 
  Global Supply Chain

  Hanwha Qcells Completes US Cell Line, Vertically Integrates North America

  Hanwha Qcells, the solar division of Hanwha Solutions, has completed the cell production line at its Cartersville plant in Georgia, United States, and confirmed the start of mass production in July. With the completion of vertical integration across the solar value chain in the United States for the

  2026.06.11
• 
  Medical / Research

  Younger Women With Stomach Cancer Have Lower Survival

  Professor Kim Na-young (left) and Professor Choi Yong-hoon of the Division of Gastroenterology, Seoul National University Bundang Hospital. Courtesy of Seoul National University Bundang Hospital The survival rate of women under the age of 50 with gastric cancer has been found to be lower than that o

  2026.06.10
• 
  Pharmaceutical R&D

  ‘We’ll Help Advance Korea’s Bio Sovereignty’

  Jeong Hee-jin, Head of the Vaccine Innovation Center Jeong Hee-jin, head of the Vaccine Innovation Center at Korea University College of Medicine (professor of infectious diseases at Korea University Guro Hospital), said, “Through cooperation with the government, research institutes, and industry, I

  2026.06.10
• 
  Pharmaceutical R&D

  From Outcomes to Data Science: Drug Trials Evolve

  최근 신약 개발 환경이 빠르게 변화하면서 임상시험에서 데이터관리(DM)와 통계분석(STAT)의 중요성이 더욱 부각되고 있다. 임상시험은 과거 환자 치료 결과를 중심으로 평가되던 ‘클리니컬 사이언스’ 영역에서 이제는 데이터를 기반으로 의사결정을 내리는 ‘데이터 사이언스’ 중심으로 전환되고 있다. 동시에 글로벌 규제 기관의 요구 수준이 높아지고 다국가·대규모 임상이 증가하면서 방대한 데이터를 얼마나 정확하고 일관되게 관리하고 해석하느냐가 신약 개발의 핵심 경쟁력으로 자리 잡고 있다. 이처럼 임상시험의 패러다임이 ‘데이터 중심’으로 재편

  2026.06.10